Currently out of the existing stock ratings of Kyle Bauser, 61 are a BUY (91.04%), 6 are a HOLD (8.96%).

Kyle Bauser

Work Performance Price Targets & Ratings Chart

Analyst Kyle Bauser, currently employed at ROTH MKM, carries an average stock price target met ratio of 50.98% that have a potential upside of 38.16% achieved within 230 days. Previously, Kyle Bauser worked at BTIG, CANACCORD, COLLIERS, LAKE STREET, B. RILEY.

Kyle Bauser’s has documented 124 price targets and ratings displayed on 22 stocks. The coverage is on Healthcare, Financial Services sectors.

Most recent stock forecast was given on TCMD, Tactile Systems Technology at 07-May-2026.

Wall Street Analyst Kyle Bauser

Analyst best performing recommendations are on CEMI (CHEMBIO DIAGNOSTICS).
The best stock recommendation documented was for TCMD (TACTILE SYSTEMS TECHNOLOGY) at 2/18/2026. The price target of $32 was fulfilled within 1 day with a profit of $1.05 (3.18%) receiving and performance score of 31.77.

Average potential price target upside

of $19.61 (23.76%) on UFPT (UFP TECHNOLOGIES).
of $16.5 on SI (SILVERGATE CAPITAL).
of $12.89 (21.9%) on INSP (INSPIRE MEDICAL SYSTEMS).

CEMI Chembio Diagnostics APYX Apyx Medical BIOL BIOLASE SIEN Sientra PFMT Performant Financial UFPT UFP Technologies ELMD Electromed STRM Streamline Health Solutions VREX Varex Imaging Corp SPOK Spok Holdings CLPT Clearpoint Neuro INSP Inspire Medical Systems MYO Myomo OPRX OPTIMIZERx Corp TCMD Tactile Systems Technology LFMD LifeMD SNWV BMRA INFU InfuSystems Holdings LTRN Lantern Pharma SI Silvergate Capital SWKH

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Kyle Bauser (ROTH MKM)